EGFR and triple-negative breast carcinoma: Co-inhibition of EGFR and ROCK in triple-negative breast cancer cells caused decrease in phosphorylated pRB, p27, Cyclin A and Cdk2 protein levels, correlating with an almost complete loss of the ability of the cells to replicate and consequently, proliferate.